Schedule 13D ownership disclosure
RECURSION PHARMACEUTICALS INC CL A
Class A Common Stock, $0.00001 par value per share · CUSIP: 75629V104
Event date: 2024-11-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mubadala Investment Co PJSCReported CIK 0001704268
Shares: 0.00 · Class: 0.0%
- Mamoura Diversified Global Holding PJSCReported CIK 0001419351
Shares: 0.00 · Class: 0.0%
- MDC Capital Partners (Ventures) GP, LP
Shares: 7,062,869.00 · Class: 1.4%
- MDC Capital Partners (Ventures), LPReported CIK 0001714230
Shares: 7,062,869.00 · Class: 1.4%
- MIC Capital Management UK LLPReported CIK 0001889830
Shares: 2,581,164.00 · Class: 0.5%
- MC Alternative Solutions, LPReported CIK 0001974767
Shares: 1,388,889.00 · Class: 0.3%
- MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp
Shares: 1,192,275.00 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-25-021183
- Form type
- SCHEDULE 13D/A
- Filer
- Mubadala Investment Co PJSC
- CIK
- CIK 1704268
- Filed
- Dec 23, 2025
- Reporting period
- Nov 20, 2024
- Description
- Schedule 13D beneficial ownership